Drawing for A

USPTO serial 99726476

A

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
GREEN, OCTAVIA M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with A?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John L. DuPre'

John L. DuPre' Hamilton, Brook, Smith & Reynolds, P.C.155 Seaport Blvd.Boston, MA 02210United States

Goods and services

ClassDescriptionStatusFirst use
001Molecular biology research tools, in the nature of biological and biochemical reagents for scientific and research use, specifically clones, viral vectors, plasmids, genomic DNA, recombinant DNA, biological libraries in the nature of collections of similar plasmids, and biological entities, namely, bacteria; biological and chemical kits comprised of biological and chemical materials, namely, clones, viral vectors, plasmids, genomic DNA, recombinant DNA, biological libraries in the nature of collections of similar plasmids, and biological entities, namely, bacteria, and test tubes, vials, and related containers, all for scientific research and medical research purposesACTIVE—
005Biological and biochemical reagents for medical or veterinary purposesACTIVE—
035Distributorships featuring DNA-based and other biological reagents in support of scientific researchACTIVE—
042Providing scientific information relating to molecular biology research tools, namely, clones, viral vectors, plasmids, genomic DNA, recombinant DNA, biological libraries in the nature of collections of similar plasmids, and biological entities, namely, bacteria; providing scientific and medical research information on molecular biology research tools and protocols relating to molecular biology research tool use; providing scientific information on the use, selection, production, application, structure and activities of molecular biology research tools; providing technical support, namely, technical consultation in the field of biological research relating to molecular biology research tools selection and use; online computer services in the nature of providing a search engine for obtaining data, namely, searching, retrieving, and providing molecular biology research information tools on a global networkACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 6, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 6, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 30, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 11, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 6, 2026DOCKASSIGNED TO EXAMINER—
Aug 5, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 26, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 26, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance